FDA Inspection 1109088 — NovoSci Corporation

NovoSci Corporation — FEI 1625519

The FDA completed an inspection of NovoSci Corporation on November 7, 2019 in Conroe, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). 6 citations were issued during this inspection. Product area: Devices.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
November 7, 2019
Fiscal Year
2020
Product Type
Devices
Project Area
Compliance: Devices
Location
Conroe, TX (United States)

Citations

IDCFRDescription
311921 CFR 820.75(b)Lack/Inad procedure-Monitoring/Control of Validated Proces
333121 CFR 820.181DMR - not or inadequately maintained
405921 CFR 820.22Quality Audits - defined intervals
54121 CFR 820.70(c)Environmental control Lack of or inadequate procedures
54621 CFR 820.75(a)Lack of or inadequate process validation
63021 CFR 803.17Lack of Written MDR Procedures